Ad is loading...
GDTC
Price
$2.25
Change
+$0.05 (+2.27%)
Updated
Nov 22, 02:07 PM (EDT)
5 days until earnings call
RXRX
Price
$5.80
Change
+$0.05 (+0.87%)
Updated
Nov 22, 03:36 PM (EDT)
102 days until earnings call
Ad is loading...

GDTC vs RXRX

Header iconGDTC vs RXRX Comparison
Open Charts GDTC vs RXRXBanner chart's image
CytoMed Therapeutics
Price$2.25
Change+$0.05 (+2.27%)
Volume$100
CapitalizationN/A
Recursion Pharmaceuticals
Price$5.80
Change+$0.05 (+0.87%)
Volume$66.95K
CapitalizationN/A
GDTC vs RXRX Comparison Chart
Loading...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
GDTC vs. RXRX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GDTC is a Hold and RXRX is a StrongSell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (GDTC: $2.20 vs. RXRX: $5.75)
Brand notoriety: GDTC and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GDTC: 18% vs. RXRX: 210%
Market capitalization -- GDTC: $25.51M vs. RXRX: $2.35B
GDTC [@Biotechnology] is valued at $25.51M. RXRX’s [@Biotechnology] market capitalization is $2.35B. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GDTC’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • GDTC’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, GDTC is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RXRX’s TA Score shows that 4 TA indicator(s) are bullish.

  • RXRX’s TA Score: 4 bullish, 6 bearish.

Price Growth

GDTC (@Biotechnology) experienced а +3.77% price change this week, while RXRX (@Biotechnology) price change was -16.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.09%. For the same industry, the average monthly price growth was -5.02%, and the average quarterly price growth was +3.96%.

Reported Earning Dates

GDTC is expected to report earnings on May 05, 2025.

RXRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (+2.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.35B) has a higher market cap than GDTC($25.5M). RXRX YTD gains are higher at: -41.684 vs. GDTC (-55.102).
GDTCRXRXGDTC / RXRX
Capitalization25.5M2.35B1%
EBITDAN/A-350.86M-
Gain YTD-55.102-41.684132%
P/E RatioN/AN/A-
RevenueN/A64.6M-
Total CashN/A428M-
Total DebtN/A90.6M-
TECHNICAL ANALYSIS
Technical Analysis
RXRX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 12 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ALVIX11.350.10
+0.89%
American Century Focused Lg Cap Val Inv
EIPFX19.40N/A
N/A
EIP Growth and Income Investor
GTFPX27.92N/A
N/A
Goldman Sachs International Eq ESG P
DOXFX52.53-0.02
-0.04%
Dodge & Cox International Stock X
TRZYX19.38-0.19
-0.97%
T. Rowe Price Latin America Z

GDTC and

Correlation & Price change

A.I.dvisor tells us that GDTC and CVKD have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GDTC and CVKD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GDTC
1D Price
Change %
GDTC100%
-0.46%
CVKD - GDTC
29%
Poorly correlated
-3.38%
ADIL - GDTC
27%
Poorly correlated
N/A
TENX - GDTC
25%
Poorly correlated
+1.68%
QSI - GDTC
24%
Poorly correlated
-12.95%
RXRX - GDTC
23%
Poorly correlated
-4.80%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been loosely correlated with BEAM. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if RXRX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-4.80%
BEAM - RXRX
62%
Loosely correlated
-3.72%
CRSP - RXRX
57%
Loosely correlated
-2.05%
PRME - RXRX
56%
Loosely correlated
-0.67%
EXAI - RXRX
56%
Loosely correlated
N/A
NTLA - RXRX
53%
Loosely correlated
+5.18%
More